Purchase Order 75D30121P11307
Award Date 6/2/21
Potential Completion Date 6/2/22
Potential Value $100K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $35,000 firm fixed price contract to Brand Institute, Inc. to conduct a survey for renaming and standardizing laboratory tests to support pandemic response efforts. Per the notice of intent to sole source, the contractor will create and distribute a survey, analyze risks of medical errors due to product names, source participants, and research safety aspects to develop names that aid in test selection and interpretation. The contract...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Brand Institute, Inc., a for-profit organization, to conduct a survey for renaming and standardizing laboratory tests. The contract has a ceiling value of $99,990.00 and a period of performance through September 30, 2023. No set-aside was used for this award. Based on the vendor's prior contract history, it appears Brand Institute, Inc. specializes in survey research to develop...
- The Centers for Disease Control and Prevention awarded a $999,918.64 delivery order contract to the National Academy of Sciences to provide technical support services for health and scientific research studies related to the Coronavirus COVID-19 pandemic. The contract is being carried out under an indefinite-delivery, indefinite-quantity vehicle and calls for the prime contractor, the National Academy of Sciences, to support the CDC's coronavirus response efforts through July 2023. No...
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- The Centers for Disease Control and Prevention issued a $2,427,648.50 delivery order to Aegis Sciences Corporation on September 27, 2024, under the Test Surge and Data Sharing IDIQ for laboratory testing and data sharing services supporting pandemic surge response and genomic surveillance. The Test Surge and Data Sharing IDIQ is a CDC multiple-award indefinite delivery contract authorized under Executive Order 14398. Place of performance is Nashville, Tennessee. The order extends through...
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...
- This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
- <p>The Centers for Disease Control and Prevention (CDC) issued a delivery order to Laboratory Corporation of America on April 16, 2026, under the GSA Federal Supply Schedule for Medical Laboratory Testing and Analysis Services (FSS-621-II), with a ceiling value of $73,345.80.</p> <p>Place of performance is Burlington, NC. The order extends through October 15, 2031, and is priced on a firm fixed price basis. No set-aside was used.</p>
The Centers for Disease Control and Prevention (CDC) awarded a $99,990.00 firm fixed price purchase order contract to Brand Institute, Inc. to conduct a survey for renaming and standardizing laboratory tests to identify COVID-19. This sole source contract was awarded under simplified acquisition procedures due to the urgent need to improve test naming conventions during the COVID-19 pandemic. The scope of work involves creating and distributing surveys, analyzing risks of medical errors, sourcing participants, and developing test names to aid in proper selection and interpretation. No set-aside provisions were used for this contract, which has a period of performance from June 2021 to June 2022.
Generated 4/2/25, 8:12 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source - Survey for Renaming and Standardization of Laboratory Tests to Support a Pandemic Response | 75D301-21-Q-73181 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Pre-Solicitation 1/1 | 4/22/21, 11:42 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.0k | 6/2/21 |